Figure 1: Effect of resveratrol treatment on urinary ortho-tyrosine excretion. Changes of urinary ortho-tyrosine concentration (A) and urinary ortho-tyrosine/creatinine ratio (B) in study cohorts of male and female IgAN patients and control subjects at Baseline, and after resveratrol treatment for 6 week and 12 week in male and female IgAN patients.*, p<0.05.